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Abstract
Plasmodium falciparum malaria parasites, living in red blood cells, express proteins of the erythrocyte membrane protein-1
(PfEMP1) family on the red blood cell surface. The binding of PfEMP1 molecules to human cell surface receptors mediates
the adherence of infected red blood cells to human tissues. The sequences of the 60 PfEMP1 genes in each parasite genome
vary greatly from parasite to parasite, yet the variant PfEMP1 proteins maintain receptor binding. Almost all parasites
isolated directly from patients bind the human CD36 receptor. Of the several kinds of highly polymorphic cysteine-rich
interdomain region (CIDR) domains classified by sequence, only the CIDR1a domains bind CD36. Here we describe the
CD36-binding portion of a CIDR1a domain, MC179, as a bundle of three a-helices that are connected by a loop and three
additional helices. The MC179 structure, containing seven conserved cysteines and 10 conserved hydrophobic residues,
predicts similar structures for the hundreds of CIDR sequences from the many genome sequences now known. Comparison
of MC179 with the CIDR domains in the genome of the P. falciparum 3D7 strain provides insights into CIDR domain
structure. The CIDR1a three-helix bundle exhibits less than 20% sequence identity with the three-helix bundles of Duffy-
binding like (DBL) domains, but the two kinds of bundles are almost identical. Despite the enormous diversity of PfEMP1
sequences, the CIDR1a and DBL protein structures, taken together, predict that a PfEMP1 molecule is a polymer of three-
helix bundles elaborated by a variety of connecting helices and loops. From the structures also comes the insight that
DBL1a domains are approximately 100 residues larger and that CIDR1a domains are approximately 100 residues smaller
than sequence alignments predict. This new understanding of PfEMP1 structure will allow the use of better-defined PfEMP1
domains for functional studies, for the design of candidate vaccines, and for understanding the molecular basis of
cytoadherence.
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Introduction
Cycles of exponential parasite growth inside infected red blood
cells (iRBCs), followed by lysis, and immediate re-invasion of
uninfected RBCs are the hallmarks of malaria caused by P.
falciparum. Though seemingly hidden from the human immune
system inside the iRBC, P. falciparum expresses a number of
proteins on the iRBC surface, extensively remodeling the iRBC,
and exposing parasite antigens to the immune system (for reviews
[1–6]). Major antigens on the iRBC surface include members of
the P. falciparum erythrocyte membrane protein-1 (PfEMP1) family,
highly polymorphic and modular proteins composed of DBL
(Duffy binding-like) and CIDR (cysteine-rich interdomain region)
domains [7]. On each iRBC, a single PfEMP1 is expressed from
one of ,sixty var genes [8,9] in the parasite genome. A different var
gene can be activated during each cycle of infection, resulting in a
new surface PfEMP1 molecule, and the parasite’s evasion of
antibodies against the previously expressed PfEMP1 [10].
Var genes undergo frequent recombination and gene conversion
giving rise in the parasite population to a vast number of variant
PfEMP1 proteins [11] that are under immune system selective
pressure. PfEMP1 molecules are thought to be constrained in
sequence only to maintain binding to host receptors and thus to
mediate cytoadherence [12]. Cytoadherence prevents iRBCs from
passing through the spleen and thus being cleared from the
circulation [13]. Adherence of iRBCs to uninfected RBC (known
as rosetting) and adherence to the microvasculature (known as
sequestration) are thought to be primary causes of morbidity,
especially in cerebral and placental malaria. iRBCs adhere due to
the binding of PfEMP1 to a variety of endothelial receptors among
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chondroitin sulfate A (CSA). Almost all parasites isolated directly
from patients have the capacity to bind to CD36 [14]. iRBC appear
tomodulate immune systemresponsesbytheirbinding to CD36and
to other receptors on immune cells in the blood [15–17].
With the availability of genomic sequences from several P.
falciparum strains, the numbers of DBL and CIDR domains and the
extents of their diversity are becoming better known [18,19].
Within the ,sixty PfEMP1 sequences of the 3D7 strain of P.
falciparum, there are 130 DBL and 110 CIDR domains [8,20].
Though sequence identities among DBL and among CIDR
domains are low, short blocks of conserved residues enable the
classification of domains into families [21]. PfEMP1 domain
families have been named DBLa, DBLb, DBLc, DBLd, DBLe and
CIDRa, CIDRb, CIDRc [18] and are also consistent with the
groupings that arise from sequence similarities as performed by
ClustalW [19]. Family groupings are used together with the
position of the domain within its particular PfEMP1 to yield
domain designations such as DBL1a, CIDR1a, CIDR2b, and so
on. As an example, Figure 1A depicts the PfEMP1 molecule from
the Malayan Camp (MC) strain of P. falciparum that consists of four
DBL and two CIDR domains [22]. Correlations of domain
families with specific ligand binding have been determined
[23,24]. In the case of the CIDR families, many domains have
been tested for their binding to CD36. From these experiments,
only CIDR1a domains bind CD36; other CIDR domains, even
the closely related CIDR1a1 domains, do not [21,25,26].
Binding to CD36 by RBCs infected with the MC strain of P.
falciparum has been studied [27,28]. Experiments using labeled
PfEMP1 proteins showed that a proteolytically-cleaved portion of
PfEMP1 is capable of binding to CD36. Antibodies against a
recombinant protein corresponding to residues 576 to 808 of the
CIDR1a domain of MC PfEMP1 block adherence of iRBCs to
CD36 [29]. Further analysis of recombinant portions of the MC
PfEMP1 molecule identified a 179-residue polypeptide, MC179
(residues 576 to 754), as a minimal portion of the MC CIDR1a
domain that retained binding to CD36 [30]. Recombinant
MC179 competes with iRBCs for binding to CD36 under blood
flow conditions, resulting in the release of bound RBCs [31,32].
CIDR1a domains have been divided into three subdomains: M1,
M2, and M3 [33]. MC179 corresponds to the M2 subdomain and
M1 and M3 are the respective N-terminal and C-terminal portions
Figure 1. The MC179 structure and PfEMP1. (A) Two CIDR and
four DBL domains compose the extracellular portion of the 2924-amino
acid residue PfEMP1 molecule from the Malayan Camp (MC) strain of P.
falciparum that is expressed on the surface of an infected red blood cell.
MC179 (black box) is about 65% of the MC CIDR1a domain. Like most
PfEMP1 molecules, the MC PfEMP1 has a semi-conserved N-terminal
DBL1a-CIDR1a pair or ‘‘head structure’’ [7]. The transmembrane (TM)
segment and acidic terminal segment (ATS) are located inside the
infected red blood cell. (B) The MC179 structure is made up of three
helices (H1, dark blue; H2, light blue; H3, red) that form a three-helix
bundle and three additional helices (a, b, c; yellow) that connect H2 to
H3. (C) View of MC179 after reorienting by 90u. Cysteine side chains are
shown in orange. (D) MC179 topology diagram shows how the six
helices are connected. Lines (orange) and residue numbers identify the
positions of the three disulfide bonds and one unbonded cysteine. Two
disulfide bonds were inferred to be present (dashed lines). Three
cysteines (parentheses) were not observed in electron density. N- and
C-termini (N, C) are labeled.
doi:10.1371/journal.ppat.1000147.g001
Author Summary
Malaria parasites express proteins of the erythrocyte
membrane protein-1 family (PfEMP1) on the surfaces of
the human red blood cells that they infect. These large
proteins vary in sequence extensively, yet bind to host
receptors to allow infected cells to adhere to host tissues.
PfEMP1 proteins help parasites evade the immune system,
as the 60 PfEMP1 genes are expressed one at a time.
Sequence comparisons predict that PfEMP1 molecules are
modular, made up of Duffy binding-like (DBL) and
cysteine-rich interdomain region (CIDR) domains. Many
CIDR domains bind to the human receptor CD36. We have
analyzed the structure of the CD36-binding portion,
known as MC179, of a CIDR domain. The MC179 protein
is composed of a bundle of three helices connected by a
loop and three additional helices. Based on the structure
and sequence similarities, MC179 is a good model for the
hundreds of known CIDR sequences. In addition, the
MC179 three-helix bundle is remarkably similar to sub-
domain 3 of the known DBL structures. MC179 provides
insight into the relatedness of both kinds of PfEMP1
domains and predicts that the large PfEMP1 molecules are
polymers of three-helix bundles and their connecting
polypeptides.
MC179, a Conserved CIDR Structure
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monkeys from severe infection upon challenge with the MC strain
[34] and prevents severe anemia after infection with a heterolo-
gous strain [35].
Three-dimensional structures of DBL, but not CIDR domains,
have been available, with sequence comparisons revealing a
number of conserved hydrophobic residues and cysteines, yet with
low overall sequence identities among PfEMP1 domains [7]. We
present the structure and analysis of MC179 in the context of the
broad sequence diversity of the CIDR domains of the P. falciparum
genomes and indicate the insights into overall DBL and PfEMP1
structure that MC179 provides.
Results/Discussion
MC179 Structure and Binding to CD36
MC179 is composed of a bundle of three helices connected by
loops and three additional helices (Figure 1). The first helix (H1) of
the bundle is joined to the second helix (H2) through a disordered
fourteen-residue loop. At the end of the H2 helix there are seventy
residues in three smaller helices, a, b, and c, that form the
connection to the third helix (H3). The ‘‘V-shape’’ of MC179 is
made up of the three-helix bundle and the three helices between
the H2 and H3 helices, in the order H1-H2-a-b-c-H3. The H1
and H2 helices make many contacts with each other and are
linked by a conserved disulfide bond, Cys 32-Cys 45, that was not
visible in the electron density, but inferred to be present. The H2
and H3 helices also make many contacts with each other and are
linked by a conserved disulfide bond, Cys 49-Cys 159, that is
observed in the electron density. The H1 and H3 helices, however,
make only a few contacts within 4 A ˚ distance and are not linked by
a disulfide. The cysteine-rich area from which the domain gets its
name is located near the end of the bundle where three disulfide
bonds and one free cysteine are located (Figure 1D).
Using mammalian cells transfected to express human CD36, we
confirmed by flow cytometry that the MC179 portion of the
CIDR1a domain that had been crystallized was capable of
binding CD36. Adding MC179 to cells expressing CD36 revealed
robust binding of MC179 (Figure 2A and 2B, blue hatched peaks).
Preincubation of MC179 with soluble human CD36 produced in
insect cells diminished the binding of MC179 to the CD36-
expressing cells (Figure 2A, orange peak). This indicated that
CD36 in solution could compete with cell surface CD36 for the
binding of MC179. Preincubation of the CD36-expressing cells
with anti-CD36 antibodies that are known to block the
cytoadherence of parasitized RBC [36] prevented the binding of
MC179 to CD36 (Figure 2B, green, red, violet peaks). This result
signified that the binding of cytoadherence-blocking antibodies to
CD36 could interfere with the binding of MC179 to CD36.
The Cysteines of MC179
The cysteine-richness for which the domain is named stems
from the conserved cysteines located on the H1-H2 loop, at the N-
terminus of H2, and at the C-terminus of H3 (Figure 1D). We
directly observed four of the seven cysteines and have evidence
that six of the seven cysteines in MC179 are in disulfide bonds.
The disulfide bond Cys 49-Cys 159 between the H2 and H3
helices was observed in electron density. Two other cysteines (Cys
45 and Cys 51) at the N-terminal end of the H2 helix were also
observed in electron density. Difference electron density based on
the sulfur anomalous signal in the native X-ray dataset confirmed
the observation of each of the four cysteines. The sulfur atoms of
cysteines 32 and 41 on the loop between the H1 and H2 helices
and of cysteine 168 at the C-terminus of MC179 were not visible.
During the preparation of MC179 for crystallization, mass
spectrometry detected an adduct of the size of a cysteamine
molecule on MC179. We reasoned that one cysteine had reacted
with cystamine (the oxidized form of cysteamine) during protein
refolding, which implied that there was one free cysteine in
MC179. From comparisons with DBL domains, we concluded
that Cys 51 is the single unpaired cysteine in MC179 (see below).
In experiments to determine which cysteine possessed the adduct,
we deleted Cys 168 by truncating twelve residues from the MC179
C-terminus, resulting in the shorter MC167 construct. After
refolding, mass spectrometry of MC167 showed that two cysteines
had reacted with cystamine, indicating that the deletion of Cys 168
had generated a second free cysteine. This implied that Cys 168 in
MC179 participates in a disulfide bond. Reports that MC179 with
Cys 168 substituted by serine and a MC167-like truncated
molecule still bind CD36 [30,37] encouraged us to produce
MC167 crystals and to use them interchangeably with MC179
during the structure determination. As residues 168–179 and the
loop between H1 and H2 were not visible in the MC179 structure
(see Methods), the observed X-ray structures of MC167 and
MC179 are identical.
Mapping Mutations and Their Effects on CD36 Binding
How do MC179 and thus the CIDR1a domains of PfEMP1
molecules bind CD36? The effects of mutations chosen based on
sequence similarities in several regions of MC179 have been
reported and these mutations can now be located and defined
structurally. The substitution of Ser for Cys 45 or a double
substitution of Ser for both Cys 159 and Cys 168 abolished CD36
binding [30]. Except for those cysteines, point mutations have little
effect on CD36 binding, but changing many residues at the same
time has a large effect on CD36-binding. CD36-binding was not
affected when point mutations within helices H1 and H2 of the
three-helix bundle were made or when the residues between Cys
32 and Cys 41 on the loop connecting the H1 and H2 helices were
replaced with residues from a non-binding CIDR domain [33].
When several point mutations were placed into the same molecule,
CD36 binding diminished from 100% to 63% [21]. CD36-binding
was lost when chimeric proteins were made between the MC
CIDR1a domain and CIDR domains that do not bind CD36.
When the H1-H2, a-b-c, and a-b-c-H3 regions of MC179 were
substituted in turn with the corresponding sequences from the
non-binding CIDR domains, no binding to CD36 was detected
[21,33]. The MC179 domain appears to function as a whole in
binding CD36 and only large changes in the domain have
succeeded in affecting binding to CD36.
Three point mutations in the same molecule affected the
binding of several CIDR1a domains to CD36. The wild type
CIDR1a domain from the ItG2-CS2 parasite strain does not bind
to CD36, but spontaneous mutations that arose during in vitro
culture changed each of the residues in the sequence Gly-His-Arg,
resulting in CD36-binding [33]. Sequence comparison aligns Gly-
His-Arg with the MC179 sequence, Glu 108-Ile 109-Lys 110,
which is located at the beginning of the b helix and makes contact
with the end of the a helix (Figure 2D). Glu 108 lies just above a
hydrophobic patch in the right-hand panel of Figure 2D.
Replacing Glu-Ile-Lys with the wild type ItG2-CS2 Gly-His-Arg
sequence decreased MC179 binding to CD36 by 50% [33]. This
suggests that part of the CD36-binding region of MC179 lies
within or near the a and b connecting helices.
Recently, a chimeric protein (‘‘1640-f’’) between a non-CD36-
binding CIDR1a1 and a CD36-binding CIDR1a molecule
exhibited CD36 binding [25]. Based on sequence alignments
(Figure S2) and the MC179 structure, the 1640-f chimera
MC179, a Conserved CIDR Structure
PLoS Pathogens | www.plospathogens.org 3 September 2008 | Volume 4 | Issue 9 | e1000147Figure 2. MC179 binding to CD36. Refolded MC179 bound to CD36-transfected CHO cells as assayed by flow cytometry ([A,B]; blue hatched
peaks). (A) Incubation of MC179 with CD36-Fc fusion protein (100 mg/ml) diminished MC179 binding to CD36 on cells (orange peak). MC179 binding
was revealed with anti-MC179 Aotus immune serum. (B) MC179 binding to CD36 is inhibited by each of three anti-CD36 mAbs (peaks outlined in red,
violet, and green). The violet peak is under the red peak and is only partially visible. Binding of MC179 was visualized with an anti-pentaHis mAb. In
both panels, controls used untransfected cells (peaks outlined in black). In (A), Aotus preimmune serum yielded results (not shown) identical to the
untransfected control. (C) Ribbon diagrams of MC179 in the same orientations as (D) and (E). Three-helix bundles are located towards the center of
the figure and connecting helices are at the sides. (D) Two views of the hydrophobic surface 180u apart show a hydrophobic patch (green, at right) on
the connecting helices of MC179. Labeled residues are those reported to affect CD36-binding (see text). (E) Surface views of MC179 showing the
distribution of positive (blue) and negative (red) surface charge. The negatively charged region (red, at left) on the connecting helices is on the
opposite face from the hydrophobic patch at the right in (D).
doi:10.1371/journal.ppat.1000147.g002
MC179, a Conserved CIDR Structure
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(PFE1640w) domain and the b, c, and H3 helices from the
CIDR1a (PF10_0406) domain. It appears that the 1640-f chimera
contained two copies of the b helix. Antibodies raised against the
CIDR1a portion of the chimera inhibited CD36 binding by
erythrocytes infected with the 3D7, HB3, or FCR3 parasite strains,
which indicated that there are similar epitopes on CIDR domains
that otherwise differ from each other [25]. Where might these cross-
reactive epitopes be located? The c helix has few conserved residues
and the conserved residues of the b helix point inward toward the a
helix, though they still could be contacted by antibodies. We suggest
that the H3 helix may be the location of cross-reactive epitopes since
the side chains of some conserved residues of the H3 helix, such as
Asp 146 and His 151, extend out into solvent.
Sequences and lengths of the a and b helices in CD36-binding
CIDR1a domains vary substantially (Figure S1), which is difficult to
rationalize with CIDR1a binding to the non-polymorphic CD36
protein. In addition, mutations and chimeric molecules have
implicated several areas of the MC179 molecule in binding. An
understanding of the mechanism of binding CD36 has not been
obtained through mutational analysis of conserved residues. That
hundreds of CIDR1a sequences still bind CD36 while containing
multiple ‘‘natural’’ mutations implies that CD36-binding may derive
from the overall structure of the CIDR1a domain.
A Surface Conserved in Both CD36 Binders and Non-
Binders
We aligned the MC179-like sequences of the 110 CIDR
domains of the P. falciparum 3D7 genome (Figure S2). For each
position in the MC179 sequence, the percent of aligned sequences
having the identical residue at that position was calculated [38].
We plotted the percent sequence identity as a gradient of color
(blue) on a surface depiction of MC179 (Figure 3). This revealed a
conserved region found in all CIDR domains (Figure 3B). This
region is located between the H1 and H2 helices near to the N-
and C-termini of MC179 and contains the unpaired cysteine, Cys
51 (Figure 3B). Cys 51 is located on the H2 helix and is conserved
in all CIDR domains whether CIDR1 or CIDR2 (Figure S2).
The conserved surface shown in Figure 3B likely becomes part
of the interior of the CIDR domain in the presence of the M1
subdomain of CIDR1a that is located N-terminal to the MC179
or M2 subdomain [37]. In other words, the blue surface in
Figure 3B is predicted to be the interface between the M1 and M2
subdomains because it is conserved in all CIDR domains, is
proximal to the MC179 N-terminus, and contains the unpaired,
conserved Cys 51. In the intact CIDR domain, Cys 51 is likely
disulfide-bonded to one of the cysteines of M1. The N-terminal
part of MC179 was shown to be important in binding CD36 [30]
and MC179-analogous protein constructs from some P. falciparum
strains bound CD36 only after the polypeptides were lengthened
to include M1 [37].
Examination of the MC179 molecule reveals that the surface on
the opposite face of MC179 is little conserved (Figure 3A). The
surfaces of the a, b, and c helices are not conserved (Figure 3) and
the connecting helices in CIDR1a sequences vary in length.
Therefore, a large part of the MC179 surface is not conserved, as
most of the residues making up the surface of MC179 are not
conserved in other CIDR1a domains. We propose that much of
MC179 is exposed at the surface of the PfEMP1 molecule. Of
course, MC179 must be exposed at the surface to bind CD36.
How much of it? Perhaps 1000 A ˚ 2 would be a minimum estimate
in light of other known protein-protein interactions. MC179 has a
total solvent accessible area of 10,000 A ˚ 2. Therefore, at least 10%
of MC179 is exposed. We detected conserved patches that we
attribute to the interface with the M1 subdomain of CIDR1a and
to potential CD36 binding (see below). We did not detect a
conserved surface that might be an interface with DBL domains,
for instance, DBL1a or DBL2, although the M1 portion may
provide a conserved contact surface with DBL1a. It seems likely to
us that the CIDR1a domain has only a small surface area in
contact with the DBL domains and that more than 10% of the
area of MC179 is exposed to the bloodstream. MC179 likely
extends out from the PfEMP1 molecule, consistent with the
proximity of the MC179 N- and C-termini to the conserved patch
predicted to interface with the M1 portion. Persons living in
malaria endemic regions only slowly acquire effective antibodies
against iRBCs [39]. One or more variable MC179-like surfaces on
PfEMP1 molecules would provide a high diversity of antibody
epitopes, leading to the slow development of immunity and to the
parasite’s ability to evade the host immune response.
A Second Conserved Surface on CIDR1a Domains
The majority of PfEMP1 molecules from the 3D7 parasite strain
contain one CIDR1a domain that binds CD36 and one CIDR2b
domain that does not bind CD36 [21]. We mapped the percent
identity of the MC179 sequence with the 3D7 CIDR1a domains
(Figure S1) and with the 3D7 CIDR2b domains (Figure S3) on
Figure 3. Sequence conservation of all CIDR domains of the
3D7 genome mapped on to the MC179 structure. High to low
conservation is mapped as a color gradient (dark blue to white) on the
molecular surface of MC179. A highly conserved surface patch (dark
blue) means that a high percentage of the residues at that position in
the alignment of all 3D7 CIDR domains (Figure S2) are identical to the
surface-exposed MC179 residue. (A) View of one side of MC179 reveals
little conservation. (B) View after a rotation of 180u shows a highly
conserved region on the molecule. Cys 51 is conserved in all CIDR
domains. Other highly conserved residues that contribute to the
conserved surface between Cys 51 and the N-terminus are Trp 14, Asp
21, Trp 55, Lys 59, Glu 62, and Ile 66 (not shown). Little conservation is
seen on the surfaces of the connecting helices. The cartoons to the
right are reference diagrams in the same orientations as the surfaces. A
few highly conserved residues are not visible at the surface because
they are completely buried. Sequence alignments (Figures S1, S2 and
S3) were used as input to the Protskin server [38] to produce this figure
and Figure 4.
doi:10.1371/journal.ppat.1000147.g003
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conserved region located between the H1 and H3 helices that is
present in both kinds of domains, but is larger in CIDR1a
domains. Every CIDR domain has some identity with MC179
here, accounted for by conserved residues that make up the
interior of the three-helix bundle, but are partially exposed at the
surface of the molecule. Examples of these are three cysteines (45,
49, and 159) and two leucines (19 and 148) (Figure 4).
Contributing to this surface in CIDR1a domains are a
conserved serine and a conserved glutamic acid. In MC179, Ser
22 and the charged Glu 152 are both nearly buried and form a
hydrogen bond. Except in one PfEMP1 (PFL0020w) where Ser 22
is replaced by a cysteine residue, Ser 22 and Glu 152 are
completely conserved in CIDR1a domains, but one or both of the
residues are absent in other CIDR domains. Ser 22 becomes a
tyrosine in most other CIDR domains and Glu 152 becomes a
leucine in all other 3D7 CIDR domains (Figure 4, middle).
Although this conserved surface in CIDR1a domains with a nearly
buried glutamic acid residue might be a potential interaction
surface with CD36, mutations of Ser 22 to threonine [33] and Glu
152 to leucine [21] have not affected CD36 binding. Additionally,
Lys 147 is present in most CIDR1a sequences, within the
conserved region shown in Figure 4. In almost all CIDR2b
domains, the residue at the Lys 147 position is a cysteine (Figure 4).
CIDR Domains Are Structurally Related to DBL Domains
During the first cloning and sequencing of PfEMP1 genes,
conserved hydrophobic residues and cysteines observed in the
midst of the enormous sequence diversity of these large proteins
were used to define the DBL and CIDR domains and to suggest
their relatedness [7]. Recent crystal structures of non-PfEMP1
DBL domains [40,41] from the P. falciparum erythrocyte-binding
antigen (EBA)-175, containing tandem DBL domains F1 and F2,
and the P. knowlesi erythrocyte binding protein (Pka-DBL),
containing a single DBL domain, showed that conserved residues
are within DBL helices. We superimposed the MC179 structure
on the F1 DBL domain from EBA-175 (Figure 5A), the F2 DBL
domain from EBA-175, and the DBL domain from Pka (Figure 6).
The three-helix bundle of MC179 structurally matched each DBL
C-terminal three-helix bundle, a region that has also been named
‘‘subdomain 3’’ [41]. MC179 and all three DBL structures closely
overlaid with root mean squared (r.m.s.) deviations between 1.6–
2.0 A ˚ over the 74–77 a-carbon atoms of the three helices. The
overlay is best among the H1 and H2 helices of all four proteins
and between the regular H3 helices of MC179 and the EBA-175
F1 DBL domain. The H3 helices of EBA-175 F2 and of Pka-DBL
are mixed with irregular secondary structure and take a
meandering route along their respective H1 and H2 helices. This
structurally conserved three-helix ‘‘bundle’’ is a feature of the DBL
and CIDR protein folds and is evidence beyond their sequence
similarities for the common ancestry between the two domain
families [7].
More than main chain atoms match among the structures,
however, as even the conserved side chains in the H1, H2, H3
helices of MC179 and in the corresponding helices of the DBL
domains are in identical positions. In Figure 5B, six conserved
Trp, Phe, and Tyr side chains in the H1 and H2 helices closely
overlay between MC179 and the F1 DBL domain. In addition, the
Cys 49-Cys 159 disulfide and Cys 45 side chain of MC179 overlay
to within 3.0 A ˚ of the analogous cysteines of the EBA-175 and
Pka-DBL domains. It is clear that the MC179 and thus the
CIDR1a disulfide bonding is the same as in the DBL domains
(Figure 1D and 5B). In the MC179 numbering used in the
structure, the cysteines involved in disulfide bonds are 32–45, 41–
168, and 49–159 (Figure 5B). Cys 51 extends into solvent from the
H2 helix and is conserved in all CIDR, but not DBL domains.
Cysteines 49 and 51 form the Cys-X-Cys sequence motif that is
found in most CIDR sequences [18]. Sequence alignments and
more recently, detailed modeling studies based on the EBA-175
and Pka crystal structures, have predicted that the interiors of
DBL and CIDR domains would be held together by conserved
hydrophobic and cysteine residues and that loops would contain
the most polymorphic sequences [42,43].
The structural overlay of MC179 on the available DBL domains
also reveals the differences in the connections between the helices
of the bundle (Figure 6). A loop of approximately similar length
connects the H1 and H2 helices in both MC179 and in the
structurally known DBL domains, but the connection between the
H2 and H3 helices differs considerably between the two kinds of
domains. In the known DBL domains, the H2-H3 connections are
about 30 residues in length consisting of a small loop and helix that
vary among the three DBL domains. In MC179, the H2-H3
connection is about 70 residues in length and ranges from 30 to
100 residues in the many known CIDR sequences.
Two Three-helix Bundles in DBL Domains
While examining the similarities between MC179 and the
known DBL domains, it became evident that DBL domains are
composed of two three-helix bundles (Figure 6). As described
above, MC179 structurally matches the DBL C-terminal three-
Figure 4. Comparison of CIDR1a and CIDR2b conserved surfaces. Sequence conservation (Figures S1 and S3) has been mapped as in Figure 3.
MC179 has been rotated about 90u from the orientation in Figure 3 to show the region between the H1 and H3 helices. At left, a bright red patch
means that a high percentage of 3D7 CIDR1a domains contain the same residue at the particular position as does MC179. In the middle, a bright
violet patch means that a high percentage of 3D7 CIDR2b domains contain the same residue at the particular position as does MC179. Appearing at
the surface of both types of domain are Cys 45, Cys 49, and Cys 159 that form part of the conserved disulfide bond network and Leu 19 and Leu 148
that make a conserved interaction between H1 and H3. The unusual nearly buried Ser 22-Glu 152 pair is unique to CIDR1a domains. At position 147, a
conserved lysine is found in CIDR1a domains, but is a cysteine in most CIDR2b domains. At right is a reference diagram for the orientation of MC179
in this figure.
doi:10.1371/journal.ppat.1000147.g004
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PLoS Pathogens | www.plospathogens.org 6 September 2008 | Volume 4 | Issue 9 | e1000147Figure 5. CIDR and DBL domains have structurally identical
three-helix bundles. (A) The three-helix bundle of MC179 closely
overlays the C-terminal three-helix bundle of the F1 DBL domain of
EBA-175 (gray). MC179 superimposes similarly on the F2 DBL domain of
EBA-175 and the Pka-DBL domain (not shown). Note that the
connecting helices (yellow) extend between H2 and H3, but the DBL
subdomain–subdomain interaction is approximately 120u away be-
tween the H1 and H2 helices. This overlay models our prediction of the
DBL1a C-terminal three-helix bundle, with the yellow connecting
helices of MC179 modeling the predicted connecting helices of DBL1a
(see text). DBL subdomain 2 (S2) and subdomain 3 (S3) are labeled [41].
(B) The three-helix bundles of MC179 (pink helices) and of the F1 DBL
domain (steel blue helices) are superimposed, after an approximate
180u reorientation from (A) about the vertical axis. The connecting
helices between H2 and H3 are not shown for clarity. Note the almost
identical positions of the helices and of conserved Phe, Trp, Tyr, and Cys
side chains (red, MC179; blue, F1 DBL). Cysteines making conserved
disulfide bonds (rectangles) are from MC179 (red font) and from the F1
DBL domain (blue font). Parentheses enclose the three cysteines not
observed in the MC179 electron density. Cartoon diagram serves as a
reference for the orientation of MC179 in (B).
doi:10.1371/journal.ppat.1000147.g005
Figure 6. The three-helix bundles of MC179 and the DBL
domains. All four structures were aligned using the alpha carbon
atoms of the H1 and H2 helices, then were translated apart for viewing.
In subdomain 3, the similarity of the H1 (dark blue) and H2 (light blue)
helices is apparent, but the H3 (red) helices differ among molecules.
MC179 and the EBA-175 F1 DBL each contain regular H3 helices, but the
F2 and Pka DBL domains have irregular H3 helices. Nevertheless, these
degenerate helices meander to a pair of conserved cysteines that make
conserved bonds to H1 and H2, as in MC179 and in the F1 domain. DBL
domains contain another three-helix bundle (h1, h2, h3) in the N-
terminal half (subdomain 2) of the molecule that is colored here
analogously to the MC179 H1, H2, H3, and connecting helices. Several
characteristics of these N-terminal bundles suggest their relatedness to
the MC179 bundle and to the C-terminal DBL bundles (see text). N- and
C-termini (N, C) are labeled.
doi:10.1371/journal.ppat.1000147.g006
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terminus is also made up of three helices that are connected like
the MC179 and C-terminal DBL bundles. The sequence extents of
the N-terminal and C-terminal three-helix bundles in the
structurally determined DBL domains are: residues 58–159 and
174–282 in EBA-175 F1, residues 365–463 and 481–596 in EBA-
175 F2, residues 64–165 and 190–304 in Pka-DBL (PDB codes
1ZRL and 2C6J). In Figure 6, MC179 and the three DBL
domains are colored to highlight bundle helices and connections
between helices. MC179 structurally overlays on the DBL C-
terminal three-helix bundle, but does not overlay on the N-
terminal bundle. However, the helices and the connections
between the helices of the N-terminal bundle (h1, h2, h3) are
similar to those of the C-terminal bundle: the h1 helix (dark blue),
a short connecting loop (gray), the h2 helix (light blue), a longer
connecting helix (yellow), and the h3 helix (red) (Figure 6). Like the
C-terminal bundle, the N-terminal bundle contains a disulfide that
connects the h2 helix at its N-terminus with the h3 helix at its C-
terminus. The cysteines that compose this disulfide in each DBL
domain are: Cys 88-Cys 164 in EBA-175 F1; Cys 396-Cys 471 in
EBA-175 F2; Cys 99-Cys 176 in Pka-DBL. These disulfides pin
the h2 and h3 helices to each other and correspond to the Cys 49-
Cys 159 disulfide of MC179 and the analogous disulfides of the C-
terminal three-helix bundles of DBL domains.
Locating the H1 and H2 Helices
Based on structural similarities and conserved residues among
the CIDR and DBL domains, we developed sequence expressions
to detect the H1 and H2 helices of the three-helix bundles that can
be used to locate CIDR and DBL domains in PfEMP1 sequences.
These sequence patterns describe the conserved residues that are
unique to the H1 and H2 helices. The H1 helix sequence of CIDR
and DBL domains satisfies the expression: (Leu, Phe, Trp, or Tyr)-
X3-Trp-X17, 18, or 19-Cys, where ‘‘Xsubscript’’ indicates the number
of residues of unspecified type occurring between conserved
residues. Several possible hydrophobic residues are indicated in
parentheses at some positions. As examples, the H1 helix of
MC179 is located with the pattern Phe-X3-Trp-X17-Cys and the
predicted H1 helix of the Malayan Camp DBL1a is found with
Trp-X3-Trp-X18-Cys (Figure 7).
Different patterns of conserved residues distinguish the CIDR
H2 helices and the DBL H2 helices. The H2 helix is found in
CIDR domains by the expression: Cys-X3-Trp-X7o r8 -Trp-X6-
(Phe or Tyr). This motif is preceeded by an additional Cys-X1-i n
many CIDR domains. In DBL domains, H2 helices are predicted
with this algorithm: Cys-X3-Cys-X2-(Phe or Tyr)-X2-(Leu, Lys,
Trp, Tyr)-X7-(Phe, Trp, or Tyr)-X6-(Phe or Tyr).
We used the CIDR algorithms for H1 and H2 to detect a
CIDR-like domain in the var2csa protein, the product of a
relatively conserved gene found in all P. falciparum strains and
expressed by most parasites that bind CSA [44,45]. For example,
the var2csa family member in the 3D7 genome, PFL0030c,
contains a CIDR-like domain between the DBL2x and DBL3x
domains, two of the six DBL domains of PFL0030c. The H1
pattern of this CIDR-like domain is Leu-X3-Trp-X18-Cys and the
H2 pattern is Cys-X3-Trp-X7-Trp-X6-Tyr. We predict a three-
helix bundle in this CIDR-like domain that extends from residues
1025 to 1212 of the PFL0030c protein. This CIDR-like domain,
termed the ID (interdomain)-2 domain, has recently also been
predicted through sequence analysis and modeling [43].
MC179 Forms a Dimer in the Crystal
In the MC179 crystal, pairs of molecules interact and bury 4300
A ˚ 2 of solvent accessible surface area between them (Figure 8). A
crystallographic two-fold symmetry axis relates the two MC179
molecules. Much of the contact between the molecules is made by
the helices that connect the H2 and H3 helices including the
hydrophobic patch seen in Figure 2D. Helix a residues (Leu 94,
Leu 95, Leu 96, Ile 98, Ile 99) and helix b residues (Ile 112, Leu
115, Leu 116) constitute this hydrophobic area on one molecule,
interacting with H1 helix residues (Trp 12, Val 15, Leu 19, Ile 20,
Ile 23) and H3 helix residues (Thr 144, Lys 147, His 151) of the
symmetry-related MC179 molecule. Hydrophobic areas in the
third connecting helix, helix c, also contribute to this interaction
between molecules in the crystal. Opposite to the hydrophobic
patch on the a, b, and c helices is a region made up of negative
charges from helix a residues (Glu 97, Asp 101), helix b residues
(Glu 113, Glu 117), and a helix c residue (Asp 125) (Figure 2E, left
side in red). These charges are on the surface of the
crystallographic dimer. The molecular surface of the crystalline
dimer shows the intertwining of the two molecules in a
‘‘handshake’’-like interaction (Figure 8B). The surface comple-
mentarity (SC) index of the monomer-monomer interface is high
at 0.70 [46] and 55 residues (220 atoms) from each molecule take
part in the interaction. Residues that when mutated have affected
CD36 binding (His 69, Glu 108, Ile 109, Lys 110) contribute to the
surface of the MC179 dimer and, except for His 69, are located
near, but not in, the dimer interface (Figure 8B). His 69 is distant
from the dimer interface.
The interaction between MC179 molecules in the crystal
resembles a biological interaction with its large amount of buried
surface area and high surface complementarity. In solution, when
refolded MC179 was prepared by size exclusion chromatography,
we separated molecular species with the mobility of dimers from
the desired species with the mobility of monomers and used the
monomers for crystallization. In addition, chemical cross-linking
experiments indicated the presence of MC179 dimers in solution
(data not shown). We conclude that MC179 has the tendency to
dimerize in solution. How these dimers of a recombinant fragment
of PfEMP1, if biologically relevant, might function in a PfEMP1
molecule is unclear. Based on the enormous contact area observed
in the MC179 ‘‘dimer’’ in the crystal, our hypothesis is that the
connecting helices of the MC179 portion of CIDR1a domains
bind another molecule, either a PfEMP1 domain or a ligand. This
hypothesis that the CIDR connecting helices are involved in
binding another molecule extends to our prediction of binding by
the proposed connecting helices of the DBL1a domain as
described below.
Examination of CIDR1a Sequences
Using BLAST with the MC179 amino acid sequence as probe,
we aligned the MC179 portions of the approximately 300
CIDR1a sequences from the 3D7 strain, the Ghanaian clinical
isolate, the IT strain, and P. reichenowi genomes from the Sanger
sequencing center (http://www.sanger.ac.uk/Projects/Protozoa/).
In the alignment, semi-conserved hydrophobic residues implied the
presence of the MC179 connecting helices a, b,a n dc.B yt h e i r
sequences, all CIDR1a domains appear to retain approximately the
first two connecting helices, the a and b helices, as predicted by
alignment with the MC179 sequence, but the third connecting helix
c varies greatly in length (see 3D7 CIDR1a alignment in Figure S1).
These differing CIDR1a sequences and lengths must result in
changes in the size of the V-like opening of the CIDR1a domain as
seen in the MC179 structure. The sequence composition and length
of the three connecting helices (a, b,a n dc) vary even among
CIDR1a molecules that bind CD36 (Figure S1). In some CIDR1a
sequences there are two additional cysteine residues, one located
about ten residues afterthe end of the H2 helixand the other located
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structure, these two Ca atom positions are separated by about 8 A ˚,
which could be spanned by a disulfide bond. For example,
PF10_0001 (Figure 7), PFD0630c, PFD0005w from the 3D7 strain
have such cysteines. We predict that these cysteines form a disulfide
bondthatcouldacttostabilizetheMC179structure,bylinkingthea
Figure 7. Sequence comparison of MC179, CIDR, and DBL domains. (A) Alignment of four CIDR and four DBL domains with the lines
numbered 1–8 for clarity of discussion. Lines 1–4 show MC179 and the MC179-like portions of three other CIDR domains: line 1, CIDR1a MC179; line 2,
CIDR1a of A4var PfEMP1; line 3, CIDR1a of PF10_0001 of 3D7; and line 4, CIDR2c of the MC strain (see [B]). Lines 5–8 show four DBL domains: line 5,
Pka; line 6, EBA-F1; line 7, EBA-F2; and line 8, DBL1a of MC PfEMP1. The sequence alignment is based on conserved cysteines (green), conserved
hydrophobic residues (boxed), and on superimposed X-ray structures. Note the differing lengths and high sequence diversity in regions of lines 2–8
that are aligned with the a, b, and c helices (yellow) that connect H2 and H3 of MC179. The short connection between the H2 and H3 helices in the
non-PfEMP1 DBL domains (lines 5–7) contrasts with the much longer connection observed in the MC179 structure (line 1), predicted in other CIDR
domains (lines 2–4), and predicted in DBL1a (line 8). Note the long loop in DBL1a that connects the H1 and H2 helices. The end of the H2 helix is
marked (red dot). Helices from the MC179 structure are positioned over the MC179 sequence in line 1. MC179 is numbered 1–179 based on the PDB
accession code 3C64, which is the same sequence as residues 576–754 of GenBank U27338. The other sequences are numbered as in their GenBank
or PDB depositions with accession codes: A4var, L42244; PF10_0001; CIDR2 MC, U27338; Pka, 2C6L; EBA-F1, 1ZRO; EBA-F2, 1ZRO; DBL1a MC, U27338.
(B) Diagram of the entire PfEMP1 from the MC strain showing the alternating DBL and CIDR domains as in Figure 1. Filled boxes denote locations of
the ‘‘DBL1a MC,’’ ‘‘CIDR1 MC179,’’ and ‘‘CIDR2 MC’’ sequences that are aligned in (A).
doi:10.1371/journal.ppat.1000147.g007
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and b relative to each other, which would need to be considered in
models of how CIDR1a binds CD36, as PF10_0001, PFD0630c,
and PFD0005w are CD36 binders [21].
Insights into DBL1a Domains of PfEMP1 Molecules
Comparisons of the MC179 and DBL X-ray structures with
DBL1a domain sequences indicate that DBL1a domains have a
longer H1-H2 connecting loop than do the MC179 and DBL
domains. Figure 7 presents the DBL1a domain of the MC PfEMP1
as an example. DBL1a domains also have an additional cysteine in
the H1 helix and two additional cysteines within the connecting loop
to H2 (Figure 7). The presence of extra cysteines in PfEMP1 DBL
domains has complicated the identification of conserved cysteines.
The MC179 structure will aid in the comparison of PfEMP1 DBL,
non-PfEMP1 DBL, and CIDR domains.
From the current knowledge of the MC179 and DBL X-ray
structures, it is clear that the C-terminal boundary of DBL1a
domains has sometimes been predicted to be at the end of the H2
helix of the three-helix bundle, as determined from conserved
residues and the number of residues between them (Figure 7). This
is understandable since after the end of the H2 helix there is little
sequence similarity among DBL domains to guide prediction. The
MC179 and DBL structures show that a third helix, degenerate
helix, or, conceivably, an irregular H3 structure must be present in
all DBL and CIDR domains to complete the ‘‘bundle’’. The
structures also predict that there are at least two cysteines at the C-
terminus of the third helix that make conserved bonds with Cys 41
and Cys 49 (MC179) or their homologs in the DBL domains
(Figures 5B and 7A).
This need for two cysteines at the end of the DBL domain can
be used to predict the C-terminus of the DBL1a domain and leads
to the prediction of MC179-like connecting helices in DBL1a. For
example, in the Malayan Camp sequence shown in Figure 7A (line
8, DBL1a MC), if one proceeds along the DBL1a MC sequence
from the end of the H2 helix at conserved residue Tyr 394
(Figure 7A, red dot), a single cysteine is encountered at residue
445, but a cluster of three cysteines is found at residue 475
(Figure 7A, DBL1a MC). Since two cysteines are required to form
disulfide bonds with two conserved cysteines near the start of the
H2 helix, the third helix H3 of the DBL1a must include the
multiple cysteines around residue 475 in the sequence -Cys-Glu-
Ala-Cys-Pro-Trp-Cys- (-CEACPWC-). If the DBL1a domain has
a three-helix bundle that ends around position 475, then the
length of the three-helix region is about 70–80 residues longer
than in the EBA-175 and Pka-DBL domains. This leads to the
prediction that the DBL1a domain likely has connecting helices
between H2 and H3 of about the same length (70–80 residues) as
does MC179 (Figure 7).
The definition of a longer DBL1a domain affects the predicted
start of the following CIDR1a domain. Due to the longer DBL1a
domain, the immediately following CIDR1a domain and its M1
region are predicted to be 70–80 residues shorter. This reasoning
implies that the DBL1a C-terminal region has been included in
some predictions of the CIDR1a domain. Locating the DBL
domain C-terminal boundary in this way by finding the cysteines
that end the third helix is applicable to the DBL sequence classes,
a, b, c, d, e, and to the analysis of the semi-conserved domain
pairings of DBL1a-CIDR1a, DBL2b-C2, and DBL2d-CIDR2b
that frequently appear in PfEMP1 sequences [18].
The DBL1a-CIDR1a domain pairing or ‘‘conserved head
structure’’ is present at the N-terminal end of a majority of
PfEMP1 molecules [7,8]. As the sequences that connect H2 to H3
in the DBL1a and CIDR1a domains of the MC strain appeared to
be similar in length, we examined the lengths of connecting
regions in all of the DBL1a and CIDR1a domains that are pairs in
the 3D7 genome. We counted the number of residues that connect
H2 and H3 for each DBL1a and its associated CIDR1a domain
and produced a list of forty-seven pairs of numbers, one pair of
numbers from each PfEMP1 with a conserved head structure.
Each number is the length of the connecting sequence in a DBL1a
or a CIDR1a domain. The lengths in the list are correlated with a
0.58 correlation coefficient (Spearman rank-order) between them
(p,0.0001) (Figure S4). This positive length correlation between
DBL1a and CIDR1a implies that the connecting sequences of the
DBL1a domains are similar in length to the CIDR1a connecting
regions. This may simply reflect the evolutionary relatedness of the
two domains, but may indicate similar binding or other function.
The H2-H3 connecting helices of DBL1a may extend away
from the PfEMP1 molecule, as is the prediction for MC179 based
on the present structural analysis. The connecting helices in
MC179 extend out from the H1-H3 side of the bundle. In DBL1a,
we predict that the connecting helices would also extend out from
the H1-H3 side of the bundle. This is distinct from the H1-H2 side
that interacts with the N-terminal bundle (‘‘subdomain 2’’ [41])
(Figures 5A, 6). The overlay of the DBL domain and MC179 in
Figure 5A also serves as a model for DBL1a, if one looks at the
connecting helices of MC179 as modeling the predicted
connecting helices of DBL1a. In addition, it is possible that the
DBL1a and CIDR1a domains interact with each other in a
manner resembling the MC179 dimer in the crystal.
Figure 8. MC179 forms a dimer in the crystal. (A) Contact
between the molecules is primarily between the helices (yellow) that
connect the H2 and H3 helices and between the H1 (dark blue) to H3
(red) sides of the three-helix bundles. (B) The molecular surface of the
crystalline dimer shows the intertwining of the two molecules in a
‘‘handshake’’ manner. One molecule (at right) is colored by sequence
conservation in a ramp of blue to white as in Figure 3, and the other
molecule (at left) is colored gray for contrast. The total buried solvent-
accessible surface area is 4300 A ˚2. The surface complementarity is 0.70
[46] and 55 residues (220 atoms) from each molecule take part in the
interaction. The two MC179 molecules are related by a crystallographic
two-fold symmetry axis. The locations of several residues are indicated.
doi:10.1371/journal.ppat.1000147.g008
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boundary as described here. First, Plasmodium proteins frequently
have regions of low sequence complexity inserted in loops and
between domains [47,48]. In the PFL1960w 3D7 PfEMP1
sequence, there is an insertion of 110 glycine and serine residues
after the multiple cysteines that mark the end of the DBL1a H3
helix and before the start of the CIDR1a domain. Binding studies
with the CIDR1a domain from PFL1960w showed that it does
bind CD36 [21], indicating that the insertion did not interfere with
CD36 binding. This is consistent with the locations of the end of
the DBL1a and the beginning of the CIDR1a domain as proposed
here. Second, although MC179 is the minimal portion of the MC
CIDR1a that binds CD36, two other recombinant CIDR1a
domains bind CD36 only after the domains are lengthened in the
N-terminal direction to be longer than MC179 [37]. The minimal
lengthening needed to enable these two other CIDR1a domains to
bind CD36 extended to just before the end of the DBL1a domains
as predicted in this work. This is consistent with the boundary
between the DBL1a and CIDR1a domains that does not include
the DBL1a H3 helix in the CD36-binding CIDR1a domain.
The DBLb-C2 Domain
In addition to DBL and CIDR domains, a third type of domain,
C2, is found in PfEMP1 molecules. There are nineteen C2 domains
in the 3D7 genome and each is located C-terminal to a DBLb
domain. The A4var PfEMP1, containing a typical C2 domain, is
known to bind ICAM-1, an endothelial protein that is a ligand of
PfEMP1 [49]. When each of the A4var DBL and CIDR domains
were expressed using domain boundaries based on sequence
conservation, none of the expressed domains bound ICAM-1 [26].
The PfEMP1 domain that bound ICAM-1 was identified by
combining DBL2b with the following C2 domain [50]. In
subsequent studies to identify the minimal DBL2b-C2 domain that
allowed ICAM-1 binding, the C-terminus of the C2 domain was
progressively truncated [51]. ICAM-1 binding was lost when a
truncation removed, as would be predicted from the current work,
the third helix of the three-helix bundle at the C-terminus of the
DBL2b-C2 domain. Work with a P. falciparum parasite that binds
ICAM-1 also demonstrated that both DBL2b and C2 domains are
required for ICAM-1 binding, as neither DBL2b or C2 expressed
alone was able to bind ICAM-1 [52]. From these results, we suggest
that the C2 domain completes the subdomain 3 of the DBLb
domain, by providing the connecting residues and the third helix of
the three-helix bundle that has the cysteines that make disulfides to
conserved cysteines in the H2 helix. That the C2 domain contains
the third helixof the DBLb subdomain 3 hasbeen predictedrecently
from homology modeling [53].
PfEMP1 Is a Polymer of Three-Helix Bundles
Sequences of PfEMP1 proteins vary enormously to evade the
host immune response, while maintaining their binding to
endothelial receptors. Conservation of binding to CD36 in the
midst of tremendous variation in CIDR1a sequences implies an
essential role for binding in parasite survival and in disease
outcome for the host. Based on the MC179 structure and the DBL
structures known at present, the highly conserved helices and
disulfide bonds of the three-helix motif comprise the individual
domains of the molecules in the PfEMP1 and EBA families and
serve as the scaffolding on which sequence variation takes place.
The two helical bundles in DBL domains and the single bundle in
CIDR domains imply that a PfEMP1 molecule is not only
modular in domain organization, but is a polymer of helical
bundles, elaborated by connecting loops and helices. These loops
and helices exhibit extraordinary sequence polymorphism and
may be regions exposed to the bloodstream and its antibodies.
Focusing on the binding of host ligands by PfEMP1 molecules will
give insights into vaccine or drug strategies that will affect
cytoadherence, help elucidate the ways that the parasite adjusts the
functioning of the immune system, and should provide tools to
lessen the impact of malaria in endemic areas of the world.
Materials and Methods
MC179 Protein Expression and Crystallization
MC179 (residues 576–754 of GenBank U27338) and MC167
(residues 576–742) expression plasmids were transformed into
BL21 DE3-(RIL) cells, grown to an OD600 of ,1, and induced
with IPTG to produce insoluble protein (inclusion bodies). To
initiate refolding of either MC167 or MC179, guanidine-
solubilized inclusion bodies (30 mg) were then diluted to 45 ml
with 3 M guanidine-HCl and pumped (0.05 ml/min) into 1 L of
refolding buffer containing 400 mM arginine-HCl, 100 mM Tris-
Cl, 5 mM cystamine-HCl, 2 mM DTT, and 2 mM NaEDTA.
After 24 h, cystamine-HCl (50 mM) was added and allowed to
react for 1 h to block free cysteines. The solution was then
dialyzed against 10 L of water for 24 h and then against 10 L of
10 mM Tris-HCl pH 8.0 for 24 h. Protein was concentrated on
CM52 cation exchange resin using 10 mM MES-NaOH at
pH 6.0 and purified on a Superdex 75 size exclusion column.
Protein fractions were concentrated to 6 mg/ml with CentriPrep
concentrators. Using the hanging drop method, bipyramidal
hexagonal MC167 or MC179 crystals grew in 27% polyethylene
glycol (PEG) 400, 100 mM NaCl, 50 mM sodium citrate, pH 4.2,
and diffracted to 2.7 A ˚ using X-rays from a rotating anode
generator. PEG400 (30% v/v) cryoprotected the frozen crystals.
Seleno-methionine-containing inclusion bodies were produced in
minimal medium (Athena Enzyme Systems, FL) using the BL21-
(DE3)-X strain that is auxotrophic for methionine. Selenomet-
MC167 or MC179 was refolded and purified similarly to native
and the presence of selenium was verified by mass spectrometry.
Selenomethionine crystals grew in 15% PEG400, 100 mM NaCl,
and 50 mM sodium citrate, pH 4.2.
X-Ray Data Collection and Structure Determination
Native, selenomethionine, and heavy atom derivative X-ray
data were integrated and scaled with the XDS package [54]
(Table 1). Seleno-methionine positions were found with SHELXD
[55]. The native, selenium, ytterbium, and osmium datasets were
used in SHARP [56] to find and refine additional heavy atom sites
and to estimate protein phases for electron density maps. After
density modification with RESOLVE [57], clear helical segments
were observed in the electron density. Using the selenium positions
as landmarks, the model was built, and then refined in the CNS
package [58] to an Rwork value of 0.25 and an Rfree value of 0.29.
No dependable model could be built for one N-terminal residue,
loop residues 30–43, and C-terminal residues 168–179. Using
model phases and highly redundant data collected with 1.54 A ˚ X-
rays, anomalous difference electron density confirmed the
positions of each sulfur atom in the model. Models were
superimposed with LSQMAN [59] and the SSM server [60].
Figures were produced with PyMOL software [61] and Jalview
[62]. Surface area calculations were performed with the PISA
server [63]. Coordinates and structure factors have been deposited
with accession code 3C64 in the RCSB Protein Data Bank.
CD36 Binding Assay
The binding of recombinant MC179 with a hexa-His tag at its
C-terminus to human CD36, expressed on stably transfected
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flow cytometry protocol similar to one described [64]. Briefly, cells
were suspended at 10
6 cells/ml in phosphate-buffered saline (PBS)
containing 0.5% bovine serum albumin and 0.1% (w/v) sodium
azide (FCA buffer). Cells (100 ml) in V-bottomed, 96-well plates
were pelleted, then resuspended in 100 ml containing 100 ng/ml
MC179 and incubated for 1 h. Following washing with PBS, an
Alexa 488-labeled anti-pentahis monoclonal antibody (100 ml)
(Novagen, San Diego, CA) or an anti-MC179 serum from an
immunized Aotus monkey were added at a final concentration of
0.8 mg/ml and 1:100, respectively. IgG1 isotype mAb (Becton
Dickinson, San Jose, CA) and Aotus pre-immune serum were
included as controls. After incubation for 30 min, cells were
washed twice in PBS and Aotus antibodies were detected with
Alexa 488-labeled goat anti-human IgG (Invitrogen, Carlsbad,
CA) (100 ml) diluted 1:250 in FCA buffer. The cells were then
incubated for 30 min, washed, resuspended in 150 ml and
analyzed by FACSort (Becton Dickinson). After staining with
0.5 mg/ml propidium iodide (PI), PI
+ cells were excluded from the
analysis. Anti-CD36 antibody clones used were 185-1G2 (Lab
Vision, Fremont, CA), CLB-IVC7 (Sanquin, Amsterdam, Nether-
lands), and 8A6 [36] (gift from Dr. J. W. Barnwell, Center for
Disease Control, Atlanta, GA). All the washing steps and
incubations were performed at 4uC. Events (10,000) were acquired
using CELLQuest software (version 3.3; Becton Dickinson) and
the data from the live cell gate were analyzed by FlowJo software
(version 6.4.1; Tree Star, San Carlos, CA).
Supporting Information
Figure S1 The CIDR1a sequences from strain 3D7 aligned with
the MC179 sequence. The alignment was produced with ClustalW
and colored in clustalx colors in the alignment editor/viewer
Jalview (http://www.jalview.org/). The MC179 helices are
positioned according to the MC179 sequence (top line) and have
colors and labels as described in the text. In the CIDR1a domains
of 3D7, there are a few duplications, so that PFD1000c_CIDR1a
is not in the alignment as it is identical to PFD0995C_CIDR1a
and MAL13P1.1_CIDR1a is not present as it is identical to
PFE0005w_CIDR1a.
Found at: doi:10.1371/journal.ppat.1000147.s001 (125 KB PDF)
Figure S2 All of the CIDR sequences from strain 3D7 aligned
with the MC179 sequence. The alignment was produced with
ClustalW and colored in clustalx colors in the alignment editor/
viewer Jalview (http://www.jalview.org/). The MC179 helices are
positioned according to the MC179 sequence (top line) and have
colors and labels as described in the text.
Found at: doi:10.1371/journal.ppat.1000147.s002 (182 KB PDF)
Table 1. X-ray data and structure refinement statistics.
Se-Met YbCl3 K2OsO4 Native
Space Group P6522 P6522 P6522 P6522
Unit cell dimensions
a, b, c (A ˚) 95.6, 95.6, 85.5 94.6, 94.6, 84.6 94.7, 94.7, 84.6 93.3, 93.3, 85.7
Wavelength (A ˚) 0.97925 1.38586 0.99998 1.5418
Resolution (A ˚) 38–2.8 (3.0–2.8) 37–2.4 (3.2–2.8) 37–2.8 (2.9–2.8) 41–2.4 (2.5–2.4)
Rsym (%) 22.5 (118) 5.5 (20.5) 6.4 (15.0) 12.6 (51.1)
I/sI 16.9 (3.7) 21.6 (7.9) 40.1 (7.0) 18.8 (5.4)
Completeness (%) 99.5 99.8 99.4 99.9
Redundancy 28.9 6.3 21.8 18.2
Refinement
Resolution (A ˚) 20–2.4
No. of reflections 9,044
Rwork/Rfree 0.25/0.29
No. of atoms
Protein 1,216
Ligand/ion 14
Water 23
Average B-values (A ˚2)
Protein 41.6
Ligand/ion 43.6
Water 42.3
R.M.S. deviations
Bond lengths (A ˚) 0.009
Bond angles (u) 1.1
Ramachandran (%)
Favored, allowed 93.6, 5.0
Generous, disallowed 0.0, 1.4
doi:10.1371/journal.ppat.1000147.t001
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PLoS Pathogens | www.plospathogens.org 12 September 2008 | Volume 4 | Issue 9 | e1000147Figure S3 The CIDR2b sequences from strain 3D7 aligned with
the MC179 sequence. Note that the connecting helices region of
CIDR2b is less variable in length than in CIDR1a sequences.
Note that some CIDR2b sequences lack cysteines 45 and 49
(MC179 numbering), for example, PF11_0007. In most domains,
these cysteines make conserved disulfides with Cys 159 and Cys
168 or the analogous residues. The alignment was produced with
ClustalW and colored in clustalx colors in the alignment editor/
viewer Jalview (http://www.jalview.org/). The MC179 helices are
positioned according to the MC179 sequence (top line) and have
colors and labels as described in the text. MAL8P1.207_CIDR2b
is not in the alignment as it is identical to PFD1235w_CIDR2b.
Found at: doi:10.1371/journal.ppat.1000147.s003 (119 KB PDF)
Figure S4 Plot of the lengths of the connecting helices of DBL1a
and CIDR1a domains. The x-axis lists the 47 PfEMP1 genes from
3D7 that contain DBL1a-CIDR1a pairs, or head structures. The
y-axis plots the lengths of the connecting helices of DBL1a (red)
and CIDR1a (blue). The line (red) is a best-fit line to the DBL1a
data. The 47 data pairs have a Spearman’s rank-order correlation
coefficient between them of 0.58 with p,0.0001.
Found at: doi:10.1371/journal.ppat.1000147.s004 (98 KB PDF)
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